Quantcast

Latest immunotherapy Stories

2014-08-31 23:00:41

Ragweed is the most common cause of fall hay fever and affects people in virtually every part of the country. AllergyEasy doctors help patients build up immunity to ragweed pollens and stop overreacting to them with hay-fever-like symptoms - and it's as easy as a few drops under the tongue. Mesa, Arizona (PRWEB) August 31, 2014 For many, fall turns daily life into an allergic mess, and ragweed is likely the culprit. Ragweed is the most common cause of fall hay fever and affects 10 to...

2014-08-31 23:00:39

For years, the standard medical advice for nut allergy sufferers has simply been to avoid nuts; however, a treatment known as sublingual immunotherapy ("oral drops") is helping patients reduce their sensitivity to nuts. Mesa, AZ (PRWEB) August 31, 2014 Stuart Agren, M.D., founder of the Family Allergy Clinic in Mesa, Arizona, prescribes sublingual immunotherapy to help his patients struggling with food allergies, which now includes tree nut allergies. Dr. Agren said that it has...

2014-08-28 12:29:18

Food desensitization trial could mean new hope for children with peanut allergies HOUSTON, Aug. 28, 2014 /PRNewswire-USNewswire/ -- For children with food allergies, a trace amount of a substance can trigger deadly anaphylaxis within minutes of ingestion - the fear of which can be life altering for many families. To give hope to these patients and their families, researchers at Texas Children's Hospital and Baylor College of Medicine are embarking on a landmark peanut immunotherapy...

2014-08-28 08:28:05

LAWRENCEVILLE, N.J., Aug. 28, 2014 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN), a leading oncology drug development company, today announced that Michael H. Tardugno, Celsion's President and Chief Executive Officer, will be presenting at the Rodman & Renshaw 16th Annual Healthcare Conference on Tuesday, September 9(,), 2014 at 10:50 a.m. Eastern Time. The conference is being held at The New York Palace Hotel in New York City. A copy of the presentation will be available on...

2014-08-27 08:27:25

ORLANDO, Fla, Aug. 27, 2014 /PRNewswire/ -- TNI BioTech Inc. (OTCQB: TNIB), ("we" or the "Company") a biotechnology company pioneering the manufacturing and marketing of innovative therapies for autoimmune diseases in emerging nations, today announced it had received payment and will make its first shipments of Lodonal(®) to the Republic of Panama and The Republic of Malawi in conjunction with our marketing partner, The Brewer Group, Inc. Commenting on the initial shipments, Noreen...

2014-08-25 08:27:12

Initial Closing is for $10 Million FREDERICK, Md., Aug. 25, 2014 /PRNewswire/ -- Vaccinogen, Inc., (OTC.QB: VGEN) a cancer immunotherapy development company, announced today that it completed the initial closing of a private placement of $80 million of units and common stock. Vaccinogen received gross proceeds of $10 million in this first closing. http://photos.prnewswire.com/prnvar/20140825/139089 Vaccinogen is preparing to start ACTIVE, a confirmatory Phase IIIb pivotal...

2014-08-19 12:28:17

SYDNEY, Aug. 19, 2014 /PRNewswire/ -- Prima BioMed Ltd (ASX: PRR; NASDAQ: PBMD; ISIN: US74154B2034) ("Prima", the "Company") today announced that the abstract entitled, "Trial evaluating overall survival in epithelial ovarian cancer (EOC) patients in second remission with an autologous dendritic cell therapy targeting mucin 1" has been accepted for a poster presentation at the Society for Immunotherapy of Cancer ("SITC") 29th Annual Meeting. The poster will be presented by Prima's...

2014-08-11 23:01:33

Darst and Landes – both of whom lost mothers to cancer – will connect with a younger demographic. Stamford, CT (PRWEB) August 11, 2014 Alliance for Cancer Gene Therapy, Inc. (ACGT) – the nation’s only nonprofit dedicated exclusively to cell and gene therapies for cancer – has announced that David Darst and Alexandra Landes have joined the foundation’s Board of Directors. Both Darst and Landes lost their mothers to cancer and share a commitment to uncovering innovative methods...

2014-08-11 08:29:29

HPV Immune Therapy VGX-3100 to Advance into Phase III PLYMOUTH MEETING, Penn., Aug. 11, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today reported financial results for the quarter ended June 30, 2014. Total revenue was $3.8 million and $6.2 million for the three and six months ended June 30, 2014, compared to $786,000 and $2.2 million for the same periods in 2013. Total operating expenses were $14.0 million and $26.3 million for the three and six months...

2014-08-11 08:28:16

TAMPA, Fla., Aug. 11, 2014 /PRNewswire/ -- Morphogenesis Inc., the Tampa-based biotech company that developed the ImmuneFx(TM) cancer vaccine for dogs, cats and horses, announces that it has chosen Florida Veterinary Referral Center & 24-Hour Emergency Hospital in Estero, FL, as the newest exclusive provider of the ImmuneFx(TM) therapy process for companion animals. ImmuneFx(TM) primes and educates the pet's own immune system to recognize and kill cancer cells without harming...


Word of the Day
pungle
  • To take pains; labor assiduously with little progress.
This word comes from the Spanish 'pongale,' put it.
Related